Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Novavax (NVAX) vs. Competitors

10,192 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
NVAXNovavax$7.96$1.33B-17.4317.06%HoldUnlock the NVAX analyst price target with TipRanks PremiumNVAXUnlock the NVAX top-analyst price target with TipRanks Premium
VIRVir Biotechnology$9.25$1.64B-7.7268.49%Strong BuyUnlock the VIR analyst price target with TipRanks PremiumNVAX vs VIRUnlock the VIR top-analyst price target with TipRanks Premium
ORICOric Pharmaceuticals$8.00$779.47M-5.68-33.67%Strong BuyUnlock the ORIC analyst price target with TipRanks PremiumNVAX vs ORICUnlock the ORIC top-analyst price target with TipRanks Premium
ABCLAbCellera Biologics$11.03$3.63B-23.18206.39%Strong BuyUnlock the ABCL analyst price target with TipRanks PremiumNVAX vs ABCLUnlock the ABCL top-analyst price target with TipRanks Premium
SANASana Biotechnology$1.88$563.31M-3.57-48.35%Strong BuyUnlock the SANA analyst price target with TipRanks PremiumNVAX vs SANAUnlock the SANA top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
NVAXNovavax7.961.3921.16%
VIRVir Biotechnology9.253.7568.18%
ORICOric Pharmaceuticals8.00-3.90-32.77%
ABCLAbCellera Biologics11.037.37201.37%
SANASana Biotechnology1.88-1.65-46.74%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts